Fluid and electrolyte homeostasis during spaceflight: Elucidation of mechanisms in a primate by Churchill, Susanne
NASA Contractor Report 177548
Fluid and Electrolyte Homeostasis
During Spaceflight:
Elucidation of Mechanisms in a Primate
Susanne Churchill
(NASA-CR-l?754d) FLU['J ANO tLEC[ROLYTE N°O-Z°08_
HQME_]STASIS CURING SPAC_FL [GHT: ELUC [_ATIPN
QF _ECtIANIS_S IN A PRIMATe (Inst. for
Circd4i,__n Physiolo,jy) ,:_j p CSCL OoC uncials
- &3,/>5 0303_6_
CONTRACT NAS2-10547
April 1990
National Aeronautics and
Space Administration
https://ntrs.nasa.gov/search.jsp?R=19900019769 2020-03-19T21:34:12+00:00Z

NASA Contractor Report 177548
Fluid and Electrolyte Homeostasis
During Spaceflight:
Elucidation of Mechanisms in a Primate
Susanne Churchill
Institute for Circadian Physiology
677 Beacon Street
Boston, Massachusetts
Prepared for
Ames Research Center
CONTRACT NAS2-10547
April 1990
NASA
National Aeronautics and
Space Administration
Ames Research Center
Moffett Field, California 94035-1000

FINAL REPORT ON SUPPORTING STUDIES PERFORMED FOR NASA CONTRACT NAS
2-I0547 (Period of Performance: 10/1/81 - 3/31/88)
Submitted to: Dr. Henry Leon, Technical Monitor
Drayton Swartz, Contracting Officer
Submitted by: Susanne Churchill, Ph.D., Project Manager and
Co-Investigator
This report covers supporting studies performed under contract NAS 2-i0547
which has funded science activities for the period 10/1/81 to 3/31/88.
I. Design of LBPP Apparatus Seal (Task 2.3.2.d, Statement of Work
2-28152)
Rationale: Previous work with this model was limited
by problems in maintaining a stable LBPP over an extended period
of time, due primarily to fluctuations caused by positional changes
of the monkey.
Method: I. Evaluate gasketing materials for a cuff that would
provide: o biocompatibility with monkey (flexible, non-irritating)
o good seal with both chair and monkey
o easy adjustment to fit each monkey
2. Evaluate a design that would use such materials to yield
a satisfactory cuff.
3. Evaluate the entire chair design to maximize animal
comfort and welfare, thus minimizing twisting and straining.
4. Test the best design in six animals exposed to LBPP for a
a period of time equivalent to anticipated ground based studies (7 days).
Results: This first study undertaken with NASA support has provided
the means whereby we are currently able to reproducibly and humanely
conduct studies of up to I0 days duration. We have designed a cuff
which meets all of the above criteria and is now routinely used in
Ii of our LBPP studies. During the course of this evaluation and redesign
we have devised modifications of the primate chair which have also
contributed to pressure stability: a water cushion to minimize pressure
sores, an adjustable foot perch to provide a comfortable squatting
position, an extended frontsgiece to permit the a_imals to lean
forward when sleeping. In addition we redesigned the horizontal back
plate and catheter tunnel to better protect the catheters as they are
routed away from the animal and outside the isolation chamber. This
system is now routinely used in all of our LBPP studies.
In seven adult squirrel monkeyssubjected to LBPPat 20 torr for 7
days, LBPPwas maintained at 19.3 +/- 0.3 torr.
Conclusions/Recommendations: The modifications detailed above have
enabled us to reproducibly and routinely work with the squirrel monkey
LBPPmodel for up to i0 days of study. Data generated from such studies
have and will continue to provide an excellent basis by which to evaluate
the usefulness of this model as an analogue for weightlessness, as well
as to understand the basic physiological mechanismsunderlying the renal
response to central volume expansion in a primate.
2. Evaluation of implanted catheter design and materials (Task 2.3.2.e
and 5.9.b., S.O.W. 2-28152)
Rationale: In previous studies it had not been possible to
simultaneously measure both blood pressures and to take blood samples
during exposure to LBPP as the rate of infusion required to maintain the
catheter patent represented a volume load to the animal; in addition the
use of 0.45% saline was apparently associated with undesired hematocrit
changes.
Method: i. A new catheter material (Renathane) which purported to be
non-thrombogenic and had been extensively tested in human subjects
was evaluated for both arterial and venous catheters. It was anticipated
that use of this material might obviate the requirement for a continuous
infusion.
2. If, however, these new catheters did clot, we intended to
determine the minimum infusion rate required to keep them patent and what
infusate would do this with the least impact on the animal's health and
physiological state.
3. Evaluate implantation technique and site to provide a
consistent system.
4. Optimize the flushing technique to maintain longevity of
indwelling lines while not compromising the health of the animal.
Results: i. Renathane evaluation
Although this material was excellent for internal use,
it was found to loose fluids to evaporation where exposed to the external
environment; loss of fluid in the external portion drew blood from the
vessel lumen to the external portion - loss of fluid from the blood
portion rendered flushing and maintenance of the catheters virtually
impossible. Therefore we devised a new catheter design using two
materials: that portion inserted into the vessel and resting in the
abdominal cavity was constructed of renathane which was in turn joined to
standard polyvinyl chloride tubing as it exited the body cavity to run
under the skin and subsequently externalized between the scapulae. This
model has been used satisfactorily both in our lab and in extensive NASA
tests and been found to function well for up to two years if maintained
according to the protocol developed as part of Method A above.
Post mortem examination of these renathane catheters shows them to be
free of overgrowth or plaque development on the outside and free of
tissue or clot buildup on the inside.
During this same study we determined that it was necessary
to reduce the size of the arterial catheter from the standard .025 x .040
inches provided by the supplier as the vessel into which it is inserted
was occasionally compromised by occlusion. To do this we evaluated
several techniques before determining that drawing out the tubing after
exposure to heated peanut oil worked best. Only tubing of a
predetermined size was utilized to manufacture the catheters.
We also evaluated means of further securing the catheter
in the abdomin to reduce strain during flushing and with normal movement
of the animal and to seal off the catheter track as it entered the
abdomen. We have met with great success using small discs of Dow Corning
sylastic sheet imbedded with nylon fibers. This has significantly
prolonged the life of our catheters.
2. Clotting
In studies designed to determine how long these
catheters provided accurate pressure readings and for the arterial
catheter, good transmission of the pulse pressure waveform, we found that
it was possible to obtain a clear signal for mean arterial pressure for
frou hours; pulse pressure, however, declined by one hour. Mean venous
pressure could be accurately recorded for up to four hours. While this
was excellent for short term recordings it was not satisfactory for the
many day experiments needed for these protocols. In a series of studies
evaluating different infusion rates, we determined that a rate Of 2.7
microliters/min (3.8 ml/day) was adequate to provide the required
fidelity without significantly effecting the volume status of the animal.
The infusate that worked best was heparinized normal saline.
This infusion was so slow as to have no impact on hematocrit even when
both lines were infused simultaneously. This technique was used
satisfactorily in a study of seven adult monkeys exposed in random order
to both LBPP and air not under pressure; arterial and venous pressures
were measured and blood samples were taken as required. These data have
been presented to the American Physiological Meeting and are being
prepared for publication.
3. Implantation Technique
Using external physical landmarks as corroborated by
post-surgical x-ray of contrast filled catheters, we have determined the
optimal length of insertion of each catheter to insure optimal placement.
This is especially important for the venous catheter which must be above
the diaphragm and below the right heart to provide a good central venous
pressure recording. Our surgical techniques were evaluated by a vascular
primate surgeon chosen by NASA and found to be satisfactory by all
criter_.
4. Flushing Technique
We have invested considerable effort in modifying the
catheter flushing technique and now have a system that we believe to be
excellent by two important criteria: patency and freedom from infection.
In addition to carefully defining the individual mechanical steps and the
associated sterility, we have worked with M. Gellai (Dartmouth Medical
School) to devise a solution which can be left in the catheters to prevent
either clotting or growth of bacteria (i:i heparinized saline I00 u/ml:50%
dextrose in water). Culture of each line weekly is used to monitor for
infection; these are consistently negative.
We have trained ARC personnel in the use of this technique in our
laboratory; they have successfuly transferred our method to ARC and
have maintained cathers patent and infection free for the required periods
of time. This procedure is detailed in Appendix A.
Conclusions/Recommendations: The catheter installation and
maintenance technique developed from these studies is reliable, low in
risk and allows collection of the targeted data for both ground based and
for the flight experiments. No further modification or study is required.
3. Blood Replacement (Task 5.9.a., S.O.W. 2-228152)
Rationale: Serial blood sampling, as would be required for
determination of plasma hormone levels, electrolytes, osmolality,
hematocrit and possibly volume space measurements, may stress and/or
volume deplete and/or modify the response to LBPP in these small primates
without adequate replacement.
Method: I. Evaluate the best method of replacing red blood cells
and plasma. Choices included replacement by pooled blood from a group of
monkeys, replacement by the monkey's own blood which had been previously
collected and frozen, and replacement of the monkey's own red blood cells
following each sampling by resuspending the packed pellet from the
centrifuged sample in saline and reinfusing.
2. To reduce the size of the required blood sample it was
necessary to develop small volume analytical systems for measurement of
osmolality and plasma electrolytes and for radioimmunoassays.
Results: I. We first evaluated the most practical technique and
the one most commonly used in other chronic studies: resuspending the
spun red blood cells in saline and reinfusing into the animal. We
successfully developed a technique to do this in the ground based
laboratory; however, due to the absolute requirement for sterile
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technique and the opportunity to introduce infection, the procedure was
time consuming and cumbersome. Nonetheless we completed a successful
study of six animals exposed to seven days of LBPP and to seven days of
air not under pressure. Animals not exposed to LBPP showed no changes in
hematocrit or plasma variables as a result of blood sampling compensated
for by this technique. In order to develop a more efficient system for
the spaceflight experiment, we worked with Dr. Henry Leon and Dr. Bob
Phillips to simplify the blood sampling technique. As a result the
onboard centrifuge was modified to accept a newly designed centrisyringe
device (a blood sampling syringe that can also serve as its own
centrifuge tube) to minimize the steps and opportunity for contamination.
To further improve the procedure, we next evaluated the reinfusion of the
packed red blood cells without resuspension; plasma losses were
compensated by a chase of normal saline equivalent to the plasma taken
for analyses. This worked very well and is now the technique of choice
in both our ground based and flight experiments.
2. Working with Dr. A. Clifford Barger, Harvard Medical School, we
have developed microvolume radioimmunoassay techniques for the measurement
of plasma aldosterone and atrial natriuretic factor, two of the key
hormones implicated in the renal response to central volume expansion.
Accuracy and reliability have been shown to be equivalent to results
generated with classic macro volume assays. At a later date we also began
work with Dr. William North, Dartmouth Medical School, to adapt his small
volume radioimmunoassay for arginine vasopressin (AVP) to squirrel monkey
plasma and urine. We have also developed a technique for flame photometry
that uses microliter volumes and with NASA support purchased a
microosmometer that requires only 50 microliters of sample.
As a result of this work we are now able to routinely measure all
hormones of interest in a single sample on the order of i ml of blood.
This represents a significant gain in terms of science yield and offers
considerable flexibility in design of additional procedures.
Conclusions/Recommendations: Development of microvolume assay
techniques and the centrisyringe/packed red blood cell + saline flush
technique has greatly improved the scientific yield from both ground
based and flight studies. These techniques are reliable, simple and
greatly reduce the risk of infection to the animal.
4. Effect of circadian rhythm on plasma constituents (Task 7.8.a.)
Rationale: In order to accurately distinguish changes in plasma
hormones due to true physiological response mechanisms from those
occurring as a result of natural (circadian) rhythms, it is important to
have baseline data on how the hormones of interest fluctuate normally in
the course of twenty four hours.
Method: Six chair-trained monkeys were surgically prepared with
catheters for blood sampling and allowed to adequately recover.
Studies were conducted by placing animals in our standard LBPPchair for
36 hours of equilibration followed by 60 hours of study during which
period blood samples were taken at various time points with sufficient
time in between to prevent an effect due to excessive blood sampling.
Sampleswere taken in all animals in randomorder at each of the following
time points: 600, 800, I000, 1400, 1800, 2000, 2200, and 200. Blood
samples were centrifuged and the plasma removedand frozen for later
analysis of sodium and potassium concentration, osmolality, and plasma
aldosterone concentration. Statistical analysis was performed using
paired t-testing as each animal acted as its owncontrol. Red blood cells
were resuspended in normal heparinized (i0 units/ml) saline and reinfused.
Results: As shownin Table I, no significant differences between
any time points were observed in plasma sodium and potassium concentration
and plasma osmolality. As shownin Figure i, there were large
fluctuations observed in plasma aldosterone concentrations. The increased
levels observed at I000 were significantly elevated (p< 0.05) over those
measured at 0800 and at 1400.
Concluslons/Recommendations: These data have a significant impact
on the design and interpretation of experimental results and emphasize
the value of separate control studies. As a result, we have chosen the
time when plasma aldosterone is most stable for the majority of our
ground based studies where is important to understand whether changes in
levels of this critical hormone play a role in the observed renal
responses.
5. Engineerin_ Requirements Study (Task 7.8.b)
Rationale: To facilitate the engineering team's efforts to support
the stated science goals of our experiment as design and implementation
of the flight cage system progressed it was clearly necessary to provide
the range of certain critical biological parameters.
Methods: See original reports (Appendix) filed following completion
of this task (originally Supporting Study 4). Two such studies were
conduced at }{MS with the support of the ARc Engineering Team on 11/29/82
and 3/24/83.
6. Feasibility Study (Task 7.8.c)
Rationale: It was clearly critical at an early stage to determine
whether it was possible to integrate the fully instrumented squirrel
monkey (integration of Experiments 223 and 039) into the current flight
cage model and generate all of the required data. This study was
designed to do this as well as provide the engineering team with critical
input regarding biocompatibility of their systems and the monkey and to
6
provide the crew with a training and evaluation opportunity. This study
occurred on October 19-29, 198A at ARC.
Methods: Four restraint trained squirrel monkeys were surgically
prepared with venous and arterial catheters and a biotelemetry implant at
the Ames Research Center where all such integrated studies were
performed. Following surgical recovery, these animals were used in a
series of tests to evaluate the restraint system, the urine collection
system, functioning of the prototype feeder, blood draw system,
functioning of the waste tray system, the vascular monitoring system, and
skin thermistor system as measured from five externally attached sensors.
The specific protocol for the major feasibility study in enclosed in the
Appendix.
Results: As above these results were primarily observational in
nature and were critical in evaluating the prototype systems. See
evaluation letter in Appendix.
Conclusions/Recommendations: Such studies are absolutely critical
in the evolution of a complicated experiment such as this. It is
especially important that all levels of equipment be tested on real
subjects as soon and as often as possible.
7. Influence of Circadian Timin_ of Weightlessness Onset (Task 7.8.d)
Rationale: Previous data from this and other laboratories have
indicated that the renal response to a volume load is quite different
when the load is administered during the day as opposed to at night. To
determine whether smaller gradations of response occurred during the
daylight hours and thus whether time of launch might influence the renal
response to weightlessness, it was important to evaluate the response to
LB?P in the morning and in the afternoon.
Methods: Chair-trained squirrel monkeys were surgically implanted
with arterial and venous catheters. After appropriate recovery animals
were subjected to LBPP at 20 torr at either 10 a.m. or 2 p.m. for a
period of 24 hours. Urinary responses, central venous and arterial
pressures, and plasma hormones and electrolytes, osmolallt-y and
hematocrit were monitored and compared between the two groups.
Results: We observed no discernible influence of the time of I,BPP
onset and the renal excretory response. Urine volume and the excretion of
sodium and potassium were all increased and urine osmolallty decreased by
24 hour exposure to LBPP in all animals. As shown in accompanying figure,
there were no difference between the I0 am and 2 pm groups for any of
these variables.
Renal excretory response to 24 hr I_BPP - 10 am vs. 2 pm onset
00
O0
_m
DAy 2 DAY 3
Conclusions/Recommendations: We conclude that we have at least
several hours of latitude within the daylight hours during which the renal
response to LBPP is quite consistent. Nonetheless, we propose that large
deviations from the time-frame of our protocol be limited since previous
experiments demonstrated a dramatic difference in the response to LBPP at
night versus day.
8. Determination of Optimum Level of Lower Body Positive Pressure (LBPP)
Which Best Simulates the Space Fli_ht Response (Task 7.8.f)
Rationale: In order to optimize the ground based LBPP system as a
model for weightlessness it will be necessary to know what level of LBPP
best mimics the effect of weightlessness on cardiovascular and renal
response. These data were felt to be especially important as the LBPP
model has been proposed for ongoing use in post flight studies where
specific mechanisms and possible interventions would be evaluated.
Method: We proposed evaluating the response of the squirrel monkey
to several steps of LBPP: 20, 25 and 30 torr. In these studies animals
prepared as indicated in the previous protocols were to be exposed to
control conditions and each level in independent studies for the time
course of the renal and/or cardiovascular response. The parameters of
interest were urinary volume, osmolality, and electrolyte composition,
central venous and arterial pressure response, and plasma hormone levels,
electrolytes, osmolality and hematocrit.
Results: Our first study evaluated the response of seven adult male
squirrel monkeys exposed to seven days of both LBPP at 20 torr and as a
control air not under pressure. These data are presented in Figures 2-6
and in Tables 2-3. After preliminary studies to ascertain that the
monkeys and our system would tolerate a stepwise increase to 25 torr we
repeated this protocol in a group of new monkeys with no signifiant
differences being apparent in any of the parameters measured. Subsequent
preliminary studies at 30 and AO torr suggested that the animals did not
easily tolerate this degree of pressure and thus prohibited further study
at higher levels.
Conclusions/Recommendations: We believe that 20 tort of LBPP
creates a maximal central volume translocation in the squirrel monkey and
thus is the optimal level for further studies regarding characterization
of the renal response and the efferent limb mechanisms responsible for
this response.
9. Baseline Nominal Flight Conditions (Task 7.8.f.)
Rationale: To determine what physiological changes occur secondary
to the conditions accompanying launch (noise, vibration and acceleration)
9
as compared to the responses to weightlessness alone, it was clear that a
prior study whereby animals were exposed to launch conditions alone would
be of great value in interpreting the data gained from flight.
Methods: As designed, this study would have exposed the four
animals selected for EVT (fully instrumented and subjected to the full
flight protocol) to the noise, launch and vibration profiles typically
encountered during shuttle launch.
Results: Due to logistical problems, these studies were not
performed during EVT. Instead, it has been proposed that if possible
these studies be performed post flight on the actual animals.
Availability and access to a centrifuge are critical.
Concluslons/Recommendations: The rationale is extremely valid and
if at all possible, these studies should be performed as designed.
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TABLE 3¸
Free Water and Osmolar Clearances During Chronic Exposure
to Lower Body Positive Pressure and Control Conditions
Study Day of Study
CH20
LBPP
0 i 2 3 4 5 6 7 8
-.104 -.088 -.I06 -.127 -.070 -.III -.109 -.106 -.089
_.033 _.051 _.041 _.043 _.099 _.021 _.038 _.034 _.034
Control -.119
+.032
Cosm
LBPP .131
+.015
.126 -.118 -.088 -.121 -.113 .116 .102
±.037 ±.031 ±.127 ±.056 Z.042 ±.045 Z.027
.160 .153 .176 .148 .151 .150 .142
±.017 ±.022 _.022 ±.022 _.013 ±.024 ±.018
.086
+.030
.113
+.020
Control .148
+.016
.155 .150 .177 .158 .148 .155 .138
±.015 !.014 ±.022 _.023 !.017 ±.022 !.Oll
.115
+.017
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FIGURE LEGENDS
Figure 2. Effect of 7 days of lower body positive pressure (Days 1-8)
as denoted by black bar on mean arterial blood pressure in
5 squirrel monkeys. Days 0 and 9 are pre- and post-study
"control" days. Values are presented as 24-hour means ±
S.E.M. When compared with Day 8 by paired t-test, p<0.05 or
below.
Figure 3. Effect of 7 days (Days 1-8 as denoted by black bars) of lower
body positive pressure (LBPP) or no pressure (control) on
daily urinary sodium excretion, volume, and osmolality. Days
0 and 9 are pre- and post-study "control" days. Values are
presented as 24-hour means _ S.E.M. for 7 animals. When
compared by paired t-test, p<O.05 or below.
FiKure 4. Effect of first 2 days (Days i and 2) of lower body positive
pressure (LBPP) or no pressure (control) on 2-hourly urinary
sodium excretion, volume, and osmolality. Day 0 is a
pre-study "control" day. Values are presented as mean
S.E.M. for each 2-hour increment throughout the day for 7
animals. Black bars denote hours of darkness (8 p.m. to
8 a.m.). When compared by paired t-test, p<0.05 or below.
Figure 5. Effect of 7 days (Days 1-8 as denoted by black bars) of lower
15
_8
body positive pressure (LBPP) and no pressure (control) on
water and sodlumbalance. In each case balance was calculated
by comparing oral intake to urinary losses and did not include
a factor for insensible loss. Days 0 and 9 are pre- and post-
study "control" days. Values are presented as mean + S.E.M.
for 7 animals. When compared by paired t-test, p<O.05 or
below.
FiKure 6. Effect of 7 days (Days 1-8 as denoted by black bar) of lower
body positive pressure (LBPP) or no pressure (control) on
plasma aldosterone concentration. There were no differences
between groups by paired t-test on any day of the study.
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APPENDIX A
PROCEDURE FOR MAINTENANCE OF CATHETERS
I. Steam sterilize instrument tray containing Kalt clamp, gauze 2x2
pads, and needle holder.
2. Prepare and keep sterile necessary syringes:
a.
m
Wipe top of sterile saline vial with alcoho] wipe. Place
sterile needle on sterile I cc syringe and use to withdraw
approximately l/2 cc of saline from vial. The same needle can
be left in place and used for all syringes, but should be
removed immediately after thls procedure. Open sterile pack
containing two 21-gauge needle adaptors and attach syringe to
adaptor: leave in pack to maintain sterile. Prepare ]
syringe for each catheter and insert in separate bag. Each
bag will end up containing all the necessary syrlnges (3)
for flushing each individual animal.
b.
I
Use above procedure to fill same number of syringes with ] cc
of sterile saline. Attach to second needle adaptor remaining
in each of sterile packs.
o
c. Use above procedure to fill same number of sterile syringes
with dextrose;heparinized saline mixture.
Chair monkey and C-clamp back plate at appropriate angle to permit
access to catheters.
4. Unzlp jacket far enough for unhindered access to catheters.
5. Remove catheters from velcro pocket, untape and uncoil carefully
taking care not to rotate entire catheter.
6. Saturate several 2x2Ss in sterile pan with 70% ethyl alcohol.
Hold obturator with needle holder and wipe catheter from the
obturator toward the back of the monkey. Repeat several times,
o Clamp catheter with Kalt clamp taking care to position clamp
such that this can be rested on the chair without any pull on the
catheter. Throughout a11 procedures great care must be taken to
prevent the weight of the clamp failing directly on the catheter.
The tips of the clamp should be filed down slightly and protected
wit_pieces of tubing to prevent crimping or cutting of the
catheter.
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8. Using an alcohol or dry 2x2 to hold the catheter tip in one
hand, use the other hand to remove the obturator from the
catheter by grabbing with alcohol swab or needle holder.
Place the obturator in the sterile tray and cover with a
puddle of70% alcohol.
9. Syringe the tip of the catheter with a stream of 70_ ethyl alcohol.
lO. Using. an alcohol Or dry wipe to hold the catheter tip, attach
the syringe half-filled with saline, release the Kalt clamp,
and withdraw the fluid in the catheter deadspace until blood
reaches the tip of the catheter. If necessary, a slight inward
flush should be used to free the tip of the catheter of clotted
blood. Replace the Kalt clamp, remove syringe and needle adaptor
and place to one side.
]]. Attach second saline-filled syringe to catheter and release
Kalt clamp. Flush approximately .7cc of saline (this amount will
vary according to the catheter length) into the catheter at a
brisk rate. This step is designed to free the catheter lumen
from cells and clotted blood. The monkey will normal}y feel the
cool fluid and shake his upper body in response. Replace the
Kalt clamp.
]2. Remove the syringe to a non-sterile area, leaving the needle
adaptor on the catheter. Attach the dextrose:heparinized saline
syringe to the needle adaptor after first introducing r_ufficient
fluid into the needle adaptor hub to prevent the occurrence of
alr bubbles. Release Kalt clamp and carefully fil] the deadspace
of the catheter with this mixture (deadspace volume i_ _easured at
time of surgery and is usually approxlmately .]5 cc - overfill
slightly, i.e. to .2 cc).
o.
The following is very critical:
a. Maintain positive pressure on the syringe plunger (to prevent
-- back-bleeding) until the Kalt clamp is on the catheter, It
is imperative that the Kalt clamp clamp tightly enm, ugh to
prevent back flow into the catheter lumen. This obviously Is
more important for the arterial catheter than the venous,
as hydrostatic pressure is much greater in the fora=er.
13. Rinse tip of catheter with alcohol stream or dip in beaker of ethyl
alcohol. Ideally the catheter tip should be cut back with a
sterile blade at each flush (the rough edge of the end will trap
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14.
17.
18.
19.
bacteria), but for chronically-ma,intained animals this is
obviously impossible. This should, however, be cut back
periodically in order to ensure a tight fit of the obturator.
Pick up obturator with sterile needle holder and insert 3/4
of its length into the catheter. Release Kalt clamp and push
remainder of obturator into catheter, thereby displacing blood
that would have backed up into the tip when the area under the
Kalt clamp was freed. Inspect catheter for leaks around the
obturator or blood in the line.
Repeat for other catheter.
Carefully coil catheters and secure coil with adhesive tape
taking care to ensure that the catheter is not rotated and that
the obturator is safely protected. Insert catheter coils in
velcro pocket, taking great care to leave a sufficient loop of
catheter outside the pocket for adequate strain release.
Inspect entire back area carefully, paying particular attention
to the exit holes of the catheter and the skin area over the
route of the catheter under the back skin.
Close jacket zipper and secure zipper tab with a cable tie which
is passed through the zipper handle and the bottom margin of the
jacket.
Once every l to 2 weeks a sterile blood sample should be taken
from both catheters with a sterile syringe and cultured on blood
agar plates to monitor for line infections. After Step lO, blood
should actually be withdrawn into the saline-filled syringe, the
syringe and needle adaptor removed and another syringe and needle
adaptor carefully inserted, and a small blood sample taken and
transferred carefully to the shielded surface of the blood agar
plate. The sample should be streaked at a later time with a
sterile wooden stick. These plates are incubated at approprTate
temperature and time; if bacterial colonies are evident, submit
to the veterinary for identification and sensitivity testing.
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EXPER " '_IAEN_ NO. 223
_T _ _-_ r'_FLUID AND a_.C.ROLf=_ HOIvIEOSTASIS
_0R_±NG STUDY #4REPORT FOR SUP D_ _'"
ENGINEERING EVALUATION
TO: JIM DONNOLLY, NASA ARC
FROM: SUSANNE CHURCHILL, HMS
This study was conducted in order to gather baseline data in sup-
port of engineering design requirements for SL-4 experiment #223.
Two adult male flight size squirrel monkeys were studied for a
seven day period according to the standard HMS Lower Body
Positive Pressure (LBPP) control protocol. These studies were
conducted accorJing to a plan previously agreed upon by the NASA
Engineering Staff and the HMS Science Staff (Appendix f_).
Animals were placed in restraining chairs on I1/29/82; data
collection commenced the following day (11/30/82) at l0 am and
continued until i0 am on 12/7/82 (Day 7). The NASA team, Jim
Connolly and Henry Leon, were present for the first four days of
this study (11/29 -12/2/82). A preliminary report of this test
was made at the PDR meeting held at ARC 12/17/82.
PROTOCOL
Please refer to Figures 1-6 for graphic illustration of the text.
Animals #856 and #861 were selected for their general good health
and ability to tolerate extended chair sitting. On _._onday, 11/29
(Test Day 0), these two animals were placed in plexiglas
restraining chairs located inside isolation chambers with a
controlled 12 hour light-dark cycle (8am- 8pm)(Fig. 1,2). Both
animals sat on perches padded with water cushions and wore urine
collection devices designed and fabricated by Sallie Petrou of
this laboratory (Figures 3,4). Connector tubing passing from this
device through the isolation chamber floor conveys urine to a
programmable fraction collector. The scrotal area had been pre-
viously treated with Skin-Prep dressing wipes. All points of
contact with the urine device were well padded with soft foam.
Animal 856 had a special perch allowing him to squat rather than
sit with legs extended. Water was freely available from a ball
valve spout mounted on the right side of the chair at mouth
level. Food (Bio-Serve Reward Diet #T-130) was available ad lib
from a food dish fixed to the left side of the chair at waist
level. Both animals had been on this diet for a month prior to
the test. Feces were collected in a container filled with
sawdust and positioned under the animal's anus.
Both animals had indwelling arterial and venous cathers,
implanted as indicated in Table 1 according to the standard HMS
protocol. These catheters, which pass through the skin Just
below the level of the shoulder blades and extend several inches
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beyond the animal, extended, were Joined to sterile connector
tubing (lengths and specifications given in Figure 5) by a hollow
stainless steel connector. That part of the catheter which
passes under the Jacket was protected by a shield of tygon tubing
which is in turn fastened in place by ties through the back of
the Jacket. The connector tubing passes out from under the bot-
tom margin of the Jacket (still enclosed by the tygon tubing) and
travels under a lucite horizontal waist restraint plate. A thick
walled tygon shield carries the catheters from the chair to the
chamber wall where they pass through to the transducer domes,
mounted at appropriate levels (level with each catheter tip) on
the exterior of the isolation chamber (Fig. 6). The transducers
(HP#1280C) are interfaced to signal conditioners (HP #8805D)
through a computer directed multiplexer system. A Hewlett
Packard four channel recording system provides hard-copy display
of the pressures.
After the catheters were connected to the transducer domes and
the infusion begun (heparinized saline, l0 U/ml, at a rate of
0.027 ul/min into each arterial and venous catheter by means of
Harvard Apparatus pump #975), the thermistor probes (YSI #27)
were attached to the back according to the protocol set forth in
NASA Communication of 6/14/82 R. Mains to J. Connolly, "NASA/ARC
Experience with Skin Adhesives". Briefly, a small patch of hair
was shaved from the back lateral to the spine and Just under the
shoulder blades. The skin was scrubbed with a teflon pad and
sponged with alcohol. The probe was attached with cyanoacrylate
glue and a patch of microfoam tape taped over the thermistor lead
for strain relief. The temperature probe lead also ran through
the protective tygon tubing through the-cage wall to the
multiplexer.
The animals were then allowed to adjust to the restraint over-
night. At l0 o'clock Tuesday morning (Test Day I) the transducers
were zeroed and data collection was begun by means of our com-
puter driven system. Specifically:
I • Arterial and venous blood pressures were monitored con-
tinuously. These data were sampled and recorded by the
computer every 15 minutes throughout the experiment. At
the same time hard copy was provided by means of the
computer activated chart recorder (5 sec sample). With
this system data could also be accessed at any moment on
on the terminal screen. At l0 am every day all trans-
ducers were rezeroed to atmospheric pressure• Pressures
were measured and recorded as systolic, diastolic and
mean arterial pressure, and mean venous pressure.
•
Heart rate was monitored and recorded as above by means
of an HP heart rate signal conditioner (8811) enslaved
to the arterial pressure signal conditioner.
2V
_3. Skin temperature was monitored and recorded by a direct
digital output from the multiplexer to the computer•
• Urine was collected under oil in hourly samples by the
computer activated fraction collector• Samples were
measured for volume daily and frozen (4° C) for later
analysis.
• Dail F food and water consumption was determined by
weighing and recorded in the study log.
A daily (10 am) lcc blood sample was taken (method in
Appendix B), spun in a refrigerated centrifuge and the
plasma frozen (-30 ° C) for later analysis• Hematocrit
was also measured and recorded.
•
Feces were weighed daily and amounts recorded in the
log.
Daily health status assessment was made and co__ments
recorded in the computer log file.
On Test Day 7 both animals were removed from the restraint system,
bathed in warm water and checked carefully for any signs of abra-
sion or soreness. Both animals appeared in excellent health•
The photographs in Figures 1-3 were taken at this time. _lood
culture was also performed on an aliquot of the last sample and
found to be negative for both animals.
RESULTS
Mean control values and test data are presented in Tables 2-5
and Figures 7-8 as indicated below:
Body Weight
Cardiovascular Measurements
Skin Temperature
Urine Output
Food and Water Consumption
Feces Output
Table 2
Table 3
Figures 7A and B
Figures 8A and B,
Appendix C
Table 4
Table 5
DISCUSSION AND EVALUATION
We feel that this test successfully represented our typical 7-day
control study protocol. Both monkeys ate and drank appropriately
and experienced no obvious physical or psychological problems
due to the confinement. All systems, with the exception of the
skin thermistors, operated according to specification. The indi-
vidual test components are discussed below.
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We would like to emphasize, however, that this test is comparable
to what should happen during spaceflight only in the basic tech-
niques and methodologies employed and in the parameters which
need to be measured. The actual values anticipated will be quite
different and can best be estimated only by use of LBPP.
I. Body Weight. As presented in Table 2, neither animal
experienced a significant change in body weight during the study.
The decrease in weight seen in #856 during the month pre-test
reflects this animal's apparent dislike for the BioServe diet as
he had to be deprived of the normal TEKlad diet in order to
switch him onto the pelleted food. Once accustomed to it,
however, he steadily gained weight on this diet.
2. Cardiovascular Measurements. Continuous infusion of hepari-
nized saline into each arterial and venous line at the specified
rate keeps these lines patent and enables continuous monitoring
of both pressures. Data were presented as ranges (Table 2) to
provide reasonable estimations of the limits encountered during
our control studies. We anticipate that all values will be
higher during launch and re-entry and that the mean venous
pressure will be sustained higher for at leastthe first half of
the spaceflight. We find this system ideal because we are able
to 1)sample and store specific values every 15 minutes in the
computer memory, 2)have a hard copy backup of each sample and 3)
have the capacity to evaluate cardiovascular status at any
instant on the terminal screen.
Unfortunately, we have Just recently identified a number of
systems design problems with the HP 1280C pressure transducers
that may invalidate certain of the pressure measurements. These
transducers have such a prolonged mechanical settling time
following activation by the multiplexer that our values may have
been sampled (15 seconds after changing channels) before the real
pressure value was on line. While I would not expect the
arterial values to be very different from those reported, the
actual venous values may be somewhat different (same general
range, however). In addition, due to a serious negative zero
drift problem with these transducers, all venous values are 0 - 5
mm Hg below what they should be. This explains the rather unbe-
lievable and frequent very negative mean venous pressure values.
This should only be negative (and then by a few mm Hg) when the
monkey lowers his trunk below the level of the zero port on the
transducer. The occasional moderately high mean venous pressure
occurs whenever the animal speaks, defecates or micturates
(Valsalva maneuver). The one very high venous pressure (509 mm
Hg) would appear to have occurred as a result of a clot in the
llne (self correcting due to the pressure build up). We are pre-
sently correcting the transducer problem by switching to the HP
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#1290 transducer, which after careful evaluation does not have
the same problems as the 1280. The 1290 is more sensitive to
temperature shifts, however, and as this is not a linear effect
will give rise to new problems if not used in a temperature
controlled area.
2. Skin Temperature. Fixing the probes with superglue worked
quite nicely- the animals seemed to have no awareness of the
entire process or the presence of the probe. The microfoam tape
stuck well to #85W but would not stick well at all to #861. I
had occasion to open the Jacket of _85_ on day 5 in order to
retie the tygon tubing and noticed that the probe had come
unglued at that time. The probe of _861 was unglued on day 7
when the animals were removed from the protocol. I do not think
this was a fair test of the protocol however, as the tygon
shielding and the catheters undoubtedly caused a lot of pushing
and tugging on the thermistor probe. Animal #856 continued to
show a nice circadian temperature rhythm even after the PrObe
fell off (I left if free floating under the Jacket). Animal #861
also demonstrated a temperature rhythm but within a narrower
range than that seen for animal #856. This may indicate that
the probe came off fairly early into the test. The rhythm is
not very apparent in Figure 7B as the scale is compressed. I
have indicated the high and low values in the insert.
4. Urine Output. We have combined the hourly values into four
hourly sums for purposes of comparison with the flight protocol
(Figures 8A-B,Appendix C). While there is some circadian
variation in the urine volumes, there does not appear to be a
clearcut period during which urine volume is significantly
reduced. Once again, however, the definitive test for this
information remains the LSPP protocol. The highest volume
obtained for any four hour period was 32.8 ml.
5. Food and Water Consumption. Table 4, self-explanatory.
6. Feces Output. As indicated in Table 5, feces were uniformly
formed and quite dry throughout the test. Volume varied with intake.
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APPENDIX A
SL-_ COMSINED SQUI;_EL I'.',KEY E×PEk:!<ENTS TEST PL:N
GOAL
In order to obtain critical design requirement data for the major hardware
items to be developed (urine collection, blood withdrawal/infusion/
pressure, and skin thermistors) a combined experiment test should be
conducted. Re test should be done as soon as possible and minimize new
hardware and analytical technique development. The test site should be at
HMS because the Moore-Ede experiment preparation is _ore complicated and
there is full-time staff available to provide the intensive support
necessary for this effort. The projected test start date is November 29,
1982. The test should produce 72 continuous hours of data on two subjects.
Subjects could be installed on Monday and removed on Friday with the 3 days
in between as an uninterrupted data collection period.
METHOD
SUBJECTS
Description
Four adult, male, flight size (800-1200 gm) squirrel monkeys should be
selected as test candidates. The candidates should be pre-selected for
their ability to accept collar and chain handling, chair restraint and
consumption of normal caloric amounts of the specified pellet diet. T_e
animals should also be acclimated to the jacket, urine collection system
and temperature probes.
Conditioning
The four test candidates should be trained in the colony cage to daily
handling using the collar and chain. Also candidates should be gradually
conditioned (over a 6-8 week period) to tolerate 4-5 days of seated
restraint while wearing a nylon mesh restraint jacket. Subjects, should be
conditioned to eat the pellet diet and they should be placed exclusively on
this diet at least two weeks prior to the start of the test and continuing
though one week of the post-test period. After subjects are able to
tolerate 24 hours of restraint, they should have the HMS condom-type urine
collection system and dummy skin thermistors applied during most of the
remaining conditioning trials.
Surgical Implantation
The three most promising test candidates of the group of four should be
implanted with the HMS arterial and venous catheter systems a TBD time
prior to test initiation. Protective jackets should be applied to the
subjects continuously to protect the exteriorized catheters. Catheters
should be perfused periodically and maintained according to the standard
HMS procedures. Samples of blood should be withdrawn periodically via the
catheters and cultured for bacterial growth to ensure that infection is not
present.
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Selection of 2 of the 3 im.pla_ted s_b_ects w_l] be made .an the c,ornir_q ot
test day 1 by roy ewirg each subject's cor_diZior, ir.g and clinical records.
The rationale for s_bject selection should be ir, c1,Jded in the test report
prepared by HMS at the end of the test.
RDWARE
Description
At a minimum, two test hardware assemblies are required for the
conditioning and test periods and items for each subsystem are discussed
below.
Skin Temperature
Only 2 skin temperature will be measured at thoracic (central) and base of
the tail (peripheral) sites. Aa 3/16 in. O.D. Yellow Springs Instrument
(YS]) small surface ter_perature probe should be glued to the above sites
during test assembly by the method described in the report "NASA/ARC
Experience with Skin Adhesives," dated 6/14/82. The leads should be routed
_nder the jacket to an exit site below the waist divider and then to the
HMS data acquisition system. The thermistors should be taped below the
lead for strain relief.
Feeder and Control System
This system is under development by NASA/ARC but cannot be supplied to HMS
in time for this test. The BioServe small primate pellet diet will be
s_pplied ad lib to the test subjects in a small cup. The schedule for
administering the diet is described in this test plan. HMS should order
appropriate amounts of this food from BioServe, Inc.
Waterer
Water will be supplyed ad lib via a gravity-feed throughout the "
conditioning and test periods. This system should be installed on the
colony cage throughout the pre-test period.
Isolation Chamber
An enclosure with a door will provide sound and visual isolation and
environmental control for each subject. The chamber will contain the
subject and restraint system, the feed and water systems, urine colleciton
system and provide ports for exit of vascular catheters, urine colleciton
tube, water line and the thermistor leads. It will control temperature to
TBD values and provide a light/dark cycle of 12:12 with the light cycle
beginning at 0800 hours. The light level should be 600 lux for the day and
less than I lux for the night. The chamber should be opened during the
test period only for feeding and excreta collection once/day except for
emergencies. The chamber should not be opened at night except for removal
of the test subject in an emergency.
4O
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_- int at the waist with the subject in the teatedThe chair _rcv_Jes ,__tra - "
position. A _eg divider will not be _sed since leg thermistors will rot be
used and the present urine collection system does not require it. _his
chair should allow a feces collection to be made daily.
Restraint Jacket
A nylon mesh jacket will be worn by subjects at all times after
exteriorization of the vascular catheters. Also the thoracic thermistor
will be protected by the jacket from the subject.
Urine Collection System
The current _MS system includes a condom-type scrotum cup, transport tube
and 4 hour fraction collector. The fraction collector is computer
controlled and urine will be automatically collected from outside the
isolation chamber twice/day.
Blood Withdrawal/Infusion/Pressure System
This system includes arterial and venous catheters, each attached to a
pressure transducer, blood withdrawal valve and constant-rate infusion
pump, The pressure transducers monitor pressure from fluid-filled
catheters. The blood withdrawal valve permits by-passing the infusion pump
so a daily arterial blood sample can be taken in a syringe. _e infusion
system will provide constant low-flow flushing of the catheter lines with
heparinized saline to ensure catheter patency and accurate pressure
monitoring. The blood withdrawal volume, catheter infusion rate,
anti-coagulant concentration and saline fluid replacement (if used) should
closely duplicate the methods proposed for spaceflight. Vascular pressures
and heart rate (from the arterial pulse) should be measured continuously.
Development
For this test the major items that require development are: (1)'the'
computer-controlled cardiovascular data acquisition system and (2) the skin
temperature attachment method and data recording system. Development
support should be provided to HMS for item (2) by NASA/ARC.
Testing
In order to ensure that all hardware is functioning properly, a 24 hour
dry-run test should be conducted with the complete system and two fully
instrumented subjects by November 22nd so that time is allowed for
correcting any problems encountered.
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DATA
Pre-Test
The following data should be collected on the catheterized test candidates
prior to the test;
Weekly Body Weight (gin) in cage and restraint
BioServe Pellet Consumption (gin/day) in cage and restraint
Urine _roduction (approx. ml), consistency and diet influence on
Heart Rates and Vascular Pressure during restraint
Catheter Maintenance Requirements (blood culture, antibiotics, etc.)
Test
The following data should be collected on the two test subjects during the
test;
Body Weight (gm) before eating, prior to chairing
Continuous Arterial Pressure (mm Hg) with systolic, diastolic and mean
values
Continuous Venous Pressure (mm Hg) with mean values
Continuous _art Rate (beats/rain) from arterial pulse
Catheter Infusion Volume (ml/day)
Neparinized Saline Concentration (mg/ml)
BioServe Pellet Consumption (gm/day)
Water Consumption (ml/day)
Urine Production (ml/4 hr)
Feces Weight (approx. gm), consistency
Skin Temperatures (deg. C), 5 seconds duration every ]5 minutes
Daily Blood Sample (ml)
Plasma
Hematrocrit (ml)
Post-Test
The following data should be collected on the 2 test subjects for 1-4 weeks
after the test;
Body Weight (gm) before eating, after removal from chair and-at .week
intervals for 4 weeks
BioServe Pellet Consumption (gm/day) for I week in cage
Water Consumption (ml/day) for I week in cage
Feces Weight Consistency for I week in cage
Colony SKF Diet Consumption (gm/day) for 3 weeks in cage
Photos of Penis and Scrotum
Evaluation of skin thermistor attachment and lead routing (photos)
Evaluation of conditioning level of subject from physiological data.
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Test :nltiation
The test should becTn sometime on November 29 and end on December 3, ]9_2.
The subjects shoul_ be installed in the test without tranquilization. The
3rd subject will serve as a back-up throughout the test but will remain in
the colony cage otherwise. A Test Log should be kept by the Test
Coordinator (Dr. S. Churchhill) and the NASA Test Monitor. All pertinent
science and hardware-related events should be recorded. A copy of this Log
should be attached to the 30 day reports.
Daily Protocol
0_00 Lights on
- Urine collection (2000, 2400, 0400 hr samples from previous day),
note precipitate and freeze
- Record pellets eaten and refill cup
- Record water consumed and refill
Collect feces, weigh, take sample and place in freezer, dump pan and
refill with shavings
- Take I ml arterial blood sample, centrifuge, read hematocrit, remove
plasma and freeze
1200 - Urine collection (automatic)
1600 - Urine collection (0800, 1200, 1600 hr samples from this day) note
precipitate and freeze
2000 - Lights off
TEST RESULTS
HMS will provide a joint preliminary data analysis summary and a list of
recommendations to NASA within 30 days of the end of the test and a final
report within 90 days. The final report may not include complete data
analysis on the biological samples (blood, urine and feces) but should
provide as much information as possible on hardware-related methodology.
The data items listed in this report for the Pre-Test, Test and Post-Test
periods should be addressed in the reporting of test results. The NASA
test monitor will provide a test report with recommendations to the Project
within 15 days of the test conclusion.
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TABLE I
CATHETER DATA
Animal No. Species Date o_ Cathet_r
Implantation
Catheter Mater_a]
856
861
Wild Bolivian
Domestic Columbian
5/12/82
10/20/82
Renothane
Renothane
TABLE 2
BODY WEIGHT
(g)
DAY ANIMAL NO. 856 ANIMAL NO. 861
l Month
Pre-Test
Test Day 0
Test Day 7
l Month
Post-Test
1380
1330
1355
1480
1070
1075
1035
1020
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TABLE 4
FOOD AND WATER CONSUMPTION
4_
Animal No. Average For
Pre-Test Period
856 33.5
861" 41.8
856 66
861 112
0
53.6
12.5
60
175
17.7
38.9
Test Day
2 3 I 4 5 6
I
BIO-SERVE DIET CONSUMPTION (9/P_Y)
86.3 70.7 32.1 40.0
35.9 18.6 27.3 44.0
51.6
5.8
36.6
39.9
R for I-7
47.9
30.I
WATER INTAKE (mlm]]_Day_)
9O
105
120
50
83
60 93 I 902 13
93
125
127
ll5
108
97
Average for
Post-Test Period
29.6
36
65
68
* This animal tends to throw his food out of reach.
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APPENDIX B
BLOOD SAMPLE PROCEDURE (as copied from Harvard Medical School
protocol book)
Each experimental day a blood sample of 1 cc is taken from the
arterial line. The sampling port is the flush syringe port on the
3-way stopcock located 12 inches from the transducer dome (see Figure
5.
To prevent the animal from bleeding back into the line, turn
the animal "off" at the stopcock in the arterial line. Then turn off
the infusion pump. Remove the flush syringe and place on sterile
field. Place a sterile 1 cc syringe on the flush syringe port and
withdraw the saline from the line. This step is considered complete once
the blood appears non-diluted. At this stage, the fluid entering the
syringe will look considerably more viscous and, because it is heavier,
will stay in the bottom of the syringe. Close stopcock to the animal;
remove this syringe and place on sterile field.
Place a new, chilled, sterile 1 cc syringe on the sample port;
open stopcock to the animal and remove 1 cc of blood from the flush port
on the arterial line. Once this is complete, close stopcock, remove
the syringe and immediately transfer the blood to pre-labeled 1 cc conical
polypropylene tubes containing Ca-EDTA. Shake to put the EDTA in
solution and fill 2 to 3 micro-hematocrit tubes from the conical tube.
Stopper the tube and place it on ice.
Turn the pump back on and allow it to develop a pressure head.
Using the first 1 cc syringe, flush the line with the saline and blood
which was initially in the line. Reconnect the original flush syringe
and flush .I or .2 cc heparinized saline (I0 u/cc) through the line to
clear remaining blood cells. Reconnect the animal to the pump via the
stopcock.
Remove conical tube with blood from ice and spin blood down in a
cooled centrifuge. Once the blood has separated, pipet plasma from the
top and store at -30 o in a second pre-labeled polypropylene tube. Dis-
card red blood cells and check lines for air or bleeding back. Centrifuge
hematocrit tubes and read.
Materials
(2) 1 cc syringes (sterile)
(2) conical centrifuge tubes
-I containing Ca-EDTA (evaporated)
(I) centrifuges (hematocrit and standard)
(from stock solution)
(I) ice bucket
(3) micro hematocrit tubes
(I) freezer at -30°C
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EXPERIMENT NO. 223
FLUID AND ELECTROLYTE HOMEOSTASIS
REPORT ON
EVALUATION OF NASA URINE COLLECTION DEVICE UNDER LBPP CONDITIONS
TO: JIM CONNOLLY, NASA ARC
FROM: SUSANNE CHURCHILL, HMS
DATE: 21 APRIL 1983
This study was conducted in order to: I) evaluate the performance
and biocompatability of the NASA prototype urine collection system for
a 7 - I0 day period;-2) to measure urine output under conditions of
LBPP in order to approximate the size requirement for the urine collection
tubes. Two adult, male, flight-size squirrel monkeys were studied for
a 7-plus day period according to the current HMS protocol for LBPP studies.
This study was conducted according to an outline previously agreed upon by
the NASA engineering and HMS science staffs (Appendix A). Although
vascular pressure data were not required for this experiment, one animal
(No. 861) was configured in the full-up mode in order to: a) demonstrate
all phases of catheter hookup, the blood draw and reinfusion procedure,
catheter protection requirements and other maneuvers critical to the design
of flight equipment and procedures; and b) provide the HMS staff with
initial data on the fully integrated LBPP system. A protocol study by the
HMS staff had been planned prior to the test run, but due to the interaction
of NASA scheduling constraints and obligatory down-time due to minor medical
problems with each of the two subjects, this had not been possible.
Animals were fitted with a urine device and placed in restraining
chairs on 3/24/83. LBPP and data collection commenced the following day
(3/25/833 and continued for 7 days until 3/30/83. Animal No. 859 was removed
at this time as abrasions were evident. Animal No. 861 remained in his
chair through day 9-½ (_/31) and was removed at this time at the request of
the NASA staff in order to evaluate the animal's scrotal area. This same
animal participated in the previous NASA test (11-12/83). The NASA team,
Norm Donnelly and Paul Fusco, were present for the full study.
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PROTOCOL
The protocol for this study was essentially identical to that
reported previously (see report for Engineering Study No. 4, submitted
12/83, Appendix B), with the exception of the urine device and
particulars pertaining to LBPP. Each animal had worn this device at
least 24 hours two weeks prior to this test. The urine devices were
fitted by Susanne Churchill according to the NASA-ARC protocol and with
the guidance of the NASA team. The collection tube was adapted to the
HMS solenoid system which, in turn, passed urine to the fraction collector
at hourly intervals. On day 2, the waist cuffs were snugged-up and the
lower chamber sealed tightly. Air from the standard lab line was warmed
to ambient temperature and passed into these chambers until pressure,
controlled by balancing air inflow and outflow rates (outflow buffered
by passing the exit line into a deep water reservoir) remained steady at
20 mms of mercury. Pressure was maintained at 22-15 mms of mercury for
a 7-day period. Animal No. 861 was depressurized briefly on day 1 of
LBPP, per request of the NASA team, in order to evaluate apparent misfit
of the scrotal device.
Food and water consumption were measured daily. Animal health status
was evaluated at least twice daily_pening the chamber door and at will
by checking through a peephole. A blood sample was taken at 2:00 P.M.d_EIy
from animal No. 861, according to the same requirements as for the fliQht
samples. Plasma was harvested, stored and the red blood cells rediluted
and reinfused.
On dav 7 of LBPP, both animals were depressurized. Animal No. 859
was removed from the study at this time in order to inspect abrasions in the
scrotal area. Animal No. 861 was kept in the chair for an additional day
in order to evaluate urine flow after release of LBPP.
RESULTS
I. Urine Collection Device
This system appeared to function very well for the length of time
it was on each animal (8 days for No. 859; 9-½ days for No. 861). Both
animals seemed comfortable with this system and appeared to void urine
frequently. As urine was collected hourly in this test, storage function
of the tube over a 4 hour period could not be evaluated. In both animals,
a small amount of solid material, presumably ejaculate, was evident in the
upper area of the collection tube. It was also evident that in both cases
the large 0 ring would conform better to the body if shaped somewhat
differently. Specifically:
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a. Animal No. 859
This animal's scrotal support device was one provided earlier
by Paul Fusco. Although it tended to rotate down and backward, this
did not appear to impair the operation of the urine collector. BY day
8, however, small sores were evident in the monkey's groin. This was
very likely the product of adapting the system to the LAPP, however,
and not a design problem. Because the collection tube length was a little
too long, each time the solenoid valve opened and drained this sealed
system the "extra" length of reservoir tubing was sucked into the
solenoid tubing adaptor and, as a result, the entire urine system was
constantly pulled downward. This probably was the chief contributing
factor to the small groin abrasion under the large 0 ring. The animal
also sustained a cut in the right thigh from the lower edge of the upper
rubber strap. This, too, was aggravated or caused by positioning of the
LaPP cuff directly above the strap. On examination, the ventral surface
of the penis appeared somewhat irritated, apparently by the inner
surface of the flange. There appeared to be no swelling or other problems
in the penis or scrotal area. The animal was bathed and the abrasions
treated with antibiotic ointment. On examination one day later, the
abrasions were healing well, but a large serous scab was loosely attached
under the penile sheath. Three days later, healing was complete in all
areas.
b. Animal No. 861
This scrotal device was modified somewhat based on observations
made during our trial. The scrotal bag opening was increased to allow
easier entry of the scrotal sac. This increasedo_he distance between the 0
rings and the lower area. The top distance wasP_hanged from the original
one. When this animal was removed on day 9, it was noted that the large 0
ring had broken on the left side at the junction of the scrotal sac. This
had not impaired the functioning of the unit, however, which was still
firmly attached. Paul Fusco applied a syringe vacuum to the system before
it was removed and found it to be nicely sealed. This animal's scrotal
area and groin were in excellent condition, with no sign of rubbing or
abrasion. The monkey was allowed to remove the tube himself as it was quite
firmly attached. He accomplished this with great gusto and promptly ripped
the tube to shreds. ,
2. Urine Volume Under LaPP
Four hour urine outputs B_daily mean LaPPs for each animal are
presented in Figures l and 2 and in Appendix C. The normal circadian
variation in day-night urine volumes was present in both animals throughout,
with the exception of night l in animal 861. The largest 4 hour urine
volume was 17.3 ml, observed in animal 859 on day 5. The largest 4 hour
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volume observed in animal 861 was 15.5 ml on day 2. The largest hourly
void in either animal was 6.9 ml. As anticipated, animal 861 demonstrated
a brisk urine flow in the beginning two days of LBPP, followed by a
sustained and somewhat lower urine flow. It is curious that animal 859
failed to demonstrate this initial elevation in urine flow rate, especially
in light of his ingestion of large volumes of water on days 1 and 2. A
dramatic decrease in total 24 hour urine output was evident in animal 861
after removal of LBPP (mean value for LBPP days 3-7 : 46.6 mi/24 hours vs.
24.3 ml per 24 hours post-removal of pressure). Animal 859 was removed
from a chair immediately after the withdrawal of pressure.
3. Food and Water Intake
These data are presented in Table I.
4. Vascular Pressures
In order to provide the engineering staff with updated pressure
information, the limits encountered in this experiment has been determined.
These are presented in Table _. The central venous pressure data are
especially relevant given the problems encountered in the previous test
with transducer shift and the influence in this test of LBPP. High venous
pressure excursions were frequently encountered in excess of 40 mms of
mercury; these were presumbably the result of Valsalva maneuvers associated
with vocalization, micturition, or defecation. Precise definition of
this upper limit was not possible in this study as the Hewlitt Packard
chart recorder upper limit for this channel at our current range setting
was 40 mms of mercury. I have enclosed several xeroxes of typical
excursions in venous pressure as seen on the HP chart record (Appendix C).
5. Discussion/Evaluation
a. Urine Collector
The prototype version of the NASA design appeared to function
quite well for the 8 to 9 days of this test. The problems that did occur
were fe_ and were most likely due go adaptation of the collection system
to the HMS setup. Suggestions for improvement were discussed together
and summarized as follows:
I) Smooth the inside angles of the flange
2) Develop a support ring that better conforms to the
shape of the scrotal area
3) Adjust the' position of the upper straps
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TABLE 1
FOOD AND WATER CONSUMPTION
ANIMAL
NO.
859
861
859
861
1
27,4
39.6
115.3
82.8
LBPP TEST DAY
6
16.7
37.9
153.9
99.5
4 5
TEK-LAD DIET CONSUMPTION (g/Day)
24.8
i
44.9 !
35.3
23.0
20.3
27.2
72.7
76.8
WATER INTAKE (ml/Day)
57.6
II .2
74.1
77.2
121.3
104.4
97.9
103.4
95.9
56.3
for I-7
30.4
30.6
104.4
85.8
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TABLE2
RANGE OF CARDIOVASCULAR PARAMETERS
ANIMAL NO. 859
Venous Pressure (mm Hg)
Arterial Pressure* (mm Hg)
Systolic
Diastolic
Heart Rate (beats/rain)
HIGH LOW
>40 0
187 155
180 147
300 228
* This animal was somewhat hypertensive throughout the study.
$8
4) Attach the scrotal sac to the large support ring
in such a fashion as to keep the stitches away
from the point of contact with the animal
There was some concern urine volumes obtained under LBPP
from Monkey No. 859 were not consistently greate r than those seen in a
control type experiment performed last November. To rule out any negative
impact of the collection device on volume output, we will shortly rerun
this animal through an LBPP test using our urine collection device.
It would also appear advisable to begin including the rigid
inner tube, whenever possible, in the testing procedure in order to evaluate
the impact of urinary sediment and/or ejaculate on its function. As we
currently do not have the capacity to analyze urinary sediment size or
composition, it is advisable to pursue a practical evaluation as soon as
possible.
In summary, it is my opinion based on this Ig performance
that this system, once perfected, will quite adequately support the
quantitative collection of urine from the squirrel monkey. It will ob-
viously be quite important to test this system in an integrated RAHF envi-
ronment that includes the final restraint system. As the design of the
restraint system is very critical to the testing and optimal functioning of
the urine system, it is important to begin evaluating the interaction of
the two systems immediately.
bo Urine Volume Under LBPP
Due to the scheduling constraints discussed previously, this
was the first LBPP test performed in this laboratory using the new equipment
and was thus a prototype experiment. As a result, the positive air pressure
was not ideally stable throughout the experiment. However, given that each
mm of mercury rise in central venous pressure is associated with much
greater rises in applied body pressure, it is unlikely that the physiologic
stimulus caused by 15 mms of mercury was sufficiently different from that
of 20m ms of mercury to markedly affect the urine volume output. This
variatio_ would obviously be unacceptable in the more formal study which we
will be undertaking in the upcoming weeks. We will provide these data as
they become available.
Based on the recent data, and that previously published on
animals subjected to 4 days of LBPP, collection tube volumesof 30 to 40 ccs
would appear to be adequate. There will, of course, be individual voids
which may push this limit. 7n fact, it is my understanding that this was
the basis for selecting the upper limit chosen. As I reported to Norm in
my letter of 3 May 1982, the largest two-hourly void observed in the data
from the published study was 16 ccs (per 2 hours). The highest hourly void
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observed in the two animals just studied was 6.9 ccs. These high values
are fairly infrequent but unfortunately hard to predict, as the magnitude
of the response can be quite varied from animal to animal as well as for
any single animal. As we have stated previously, if the volume of an
occasional 4 hour void were to exceed the capacity of the collection tube
(~30 ccs), this would not invalidate the results.
c. Cardiovascular Parameters
Because of the fairly frequent excursions encountered in
central venous pressure, it will be important that the flight sampling
procedure be designed to avoid instantaneous samples which, if they
occurred during a chirp, etc., would not be representative of true mean
pressure. Some form of time average sample would be ideal. We have found
the backup chart record provided by HP to be critical to our evaluation
of mean pressure. This is a very important _ssue as the changes anticipated
in mean venous pressure (on the order of l-lO-lO mms of mercury) are less
than these essentially artifactual excursions.
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APPENDIX A
EXP-_=I_I<;_7 ;;O. 223
FLUID A.<D EL,ECT.n.OLZ-E EO'.IEOSCASIS
_E_ORT FOR o._- _--_ S_JD? #4 "
ENG r' ?___EERI G EVALUATION
T0: JIM .cONNOLLY, NASA ARC
FROM: SUSANNE CHURCHILL, HMS
Tnls study was conducted In. order to gather baseline data in sup-
port of engineering design requirements for SL-4 experiment #223.
Two adult male flight size squirrel monkeys were studied for a
seven day period according to the standard HMS Lower Body
Positive Pressure (LBPP) control protocol. These studies were
conducted according to a plan previously agreed upon by the NASA
Engineering Staff and the HMS Science Staff (Appendix A).
Animals were placed in restraining chairs on II/29/S2; data
collection commenced the following day (11/30/82) at I0 am and
continued until l0 am on 12/7/82 (Day 7). The NASA team, Jim
Connolly and Henry Leon, were present for the first four days of
this study (I1/29 -12/2/82). A preliminary report of this test
was made at the PDR meeting held at ARC 12/17/82.
PROTOCOL
Please refer to Figures 1-6 for graphic illustration of the text.
Animals #856 and #861 were selected for their general good health
and ability to tolerate extended chair sittlng. On Monday, 11/29
(Test Day 0), these two animals were placed in plexig!as
restraining chairs located inside isolation chambers with a
controlled 12 hour llght-dark cycle (Sam- 8pm)(Fig. 1,2). Both
animals s-at on perches padded with water cushions and wore urine
collection devices designed and fabricated by Sallie Petrou of
this laboratory (Figures 3,4). Connector tubing passing from this
device through the isolation chamber floor conveys urine to a
programmable fraction collector. The scrota! area had been pre-
viously treated with Skin-Prep dressing wipes. All points of
contact with the urine device were well padded with soft foam.
Animal 856 had a special perch allowing him to squat rather than
sit with legs extended. Water was freely available from a ball
valve spout_.mounted on the _Ight side of the chair at mouth
level. Food (Bio-Serve Reward Diet #T-130) was avail_ble ad llb
from a food dish fixed _ the left side of the chair at waist
level. Both animals had oeen on this diet for a month prior to
the test. Feces were collected in a container filled with
sawdust and positioned under the animal's anus.
Both animals had indwelling arterial and venous cathers, ......
implanted as indicated in Table 1 according to the standardHMS
protocol. These catheters, which pass •through the skin Just :
"below the level of the sh6ulder blades and extend several inches
61
i
_ • .
,>._!<.L<f'.L r_ ..,..E IS
OF POO_ QOALITY
"- te _e d,be yonJ _!_e an_ _al, ex n were Joined to sterile connector
tubing _iengths and specifications given in Figare 5) by a bol!o_
stainless steel connector. That part of the catheter which
passes ander the Jacket was protected by a shield of tygon tubing
which is in turn fastened in place by ties through the back of
the Jacket. The connector tubing passes out from under the bot-
tom margin of the Jacket (still enclosed by t!_e tygon tubing) and
travels under a lucite horizontal waist restraint plate. A thick
walled tygon shield carries the catheters from _he chair to tl_e
char ber wall where they pass ti_rough to the trans_ucer _omes,
mounted at appropriate levels (level with each catheter tip) on
the exterior of the isolation chamber (Fig. 6). The transducers
(HP#12BOC) are interfaced to s!gnal conditioners (HP _8805D)
through a computer directed multiplexer system. A _ewlett
Packard four channel recording system provides hard-copy display
of the pressures.
After the catheters were connected to the transducer domes and
the infusion begun (heparinized saline, I0 U/ml, at a rate of
0.027 ul/mln into eadh arterial and venous catheter by means of
Harvard Apparatus pump #975), the thermistor probes (¥SI #27)
were attached to the back according to the protocol set forth in
NASA Communication of 6/14/82 R. Mains to J. Connolly, "NASA/ARC
Experience with Skin Adhesives". Briefly, a small patch of hair
was shaved from the back lateral to the spine and Just under the
shoulder blades. The skin was scrubbed with a teflon pad and
sponged with alcohol. The probe was attached with cyanoacrylate
glue and a patch of microfoam tape taped over the thermistor lead
for strain relief. The temperature probe lead also ran through
the protective tygon tubing through the-cage wall to the
multiplexe r.
The animals were then allowed to adjust to the restraint over-
night. At I0 o'clock Tuesday morning (Test Day I) the transducers
were zeroed and data collection was begun by means of our com-
puter driven system. Specifically:
I. Arterial and venous blood pressures were monitored con-
tinuously. These data were sampled and recorded by the
computer every 15 minutes throughout the experiment. At
the same time _ard copy was provided by means of the
computer activated chart recorder (5 sec sample). With
this system data could also be accessed at any moment on
on the terminal screen. At I0 am every day all trans-
ducers were rezeroed to atmospheric pressure. Pressures
were measured and recorded as systollc_ diastolic and
mean arterial pressure, and mean venous pressure.
2. Heart rate was mDnitored and recorded as above by means
of an HP heart rate signal conditioner (8811)enslaved
to the arterial pressure signal conditioner.
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3. Skln tez,perature _Jas r_onltored ang recorged by a direct
_Igita! output from the rzult,lple×er to the compater.
Urine was collected under oll in hourly samples by the
computer activated fraction collector. Samples were
measured for volume daily and frozen (4 ° C) for later
analysis.
• Dally__food and water consumption was determined by
welg_Jlng and recorded in the study log.
A dally (I0 am) Icc blood sample was taken (method In
Appen41x B), spun In a refrigerated centrifuge and the
plasma frozen (-30 ° C) for later analysis. _:ematocrlt
was also measured and recorded.
•
Feces were weighed daily and anounts recor4ed In the
log.
Daily health status assessment was made and comments
recorded In the computer log file.
On Test Day 7 both anlmals were removed from the restralnt system,
bathed In warm water and checked carefully for any signs of abra-
sion or soreness• Both animals appeared in excellent health.
The photographs in Figures 1-3 were taken at thls time. _iood
culture _as also performed on an aliquot of the last sample and
found to. be negative for_bot_ anlma!s. __ ................
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APPEt_DIXB
HMS/ARCURINECULLECTIUNSYTEMIEST PLAN
l PURPOSE
The urine collection system has been successfully applied on SM's tor
periods of several hours through four days. This test is designed to: (1)
Extend the duration to 7 - IU days; (2) Determine the ettect ot LBPP on the
system; (3) Collect accurate urine output data on SM's while under the
intluence of LBPP. Ine test will also serve to simulate a 7 day mission.
II PRUCEDURE
Two SM'S who have been restraint trained tor at least seven days to the
Harvard restraint, will serve as test subjects. Ideally, both SM's will
have worn the urine collection tube continuously for 24 hours at some period
during the training. Neither animal will be instrumented with thermistors
or BTS.
The Harvard isolation chamber and programmable fraction collector will be
used, Food anO water will be available ad lib, The Harvard LBPP apparatus
will be utilized to simulate the effects ot zero-g tot a seven day period.
Daily rood and water consumption will be determined and feces weighed
weekly. Urine will be collected in hourly samples using the Harvard
traction collector.
I11PROTUCUL
Un Monday, 3/21 (Test Day 0), two animals with urine collection tubes and
flanges securely attached, will be placed in Harvard restraint chairs
located in isolation chambers with a controlled IZ hour light-dark cycle (8
am - 8 pm). The urine collection tubes will pass through the chamber
flooring to a programable fraction collector set tor hourly aliquots.
Water" will be freely available from a ball valve spout mounted at mouth
level. Food pellets will be available ad lib from a dish tixed to the chair
at waist level. Feces will be collected in a container positioned under the
animal's anus. The animals will be allowed to adjust to the restraint
overnight.
On luesdaud,morning 3/22, (Test Day I), the LBPP apparatus will be set at TBD
mm Hg and turned on. Daily measurements to be made include: (i) Hourly
urine samples, (Z) Food _water consumption & (3) Hea]th status assessment.
Part ot the health status assessment will include an examination of the
urine collection system for functionality and compatibility with the
animals.
On Tuesday morning 3/29, (Test Day 8), the LBPP apparatus will be turned ott
and the daily measurements will continue. The test will continue for I-2
more days at the discretion ot t_e PI. On the last test day, an attempt
will be made to evacuate the urine tube using a vacuutainer to determine if
the sea] on the animal's penis is still intact. The anima]s will be
carefully examined at the conclusion of the {est to assess the
biocompatibi|ity of the urine collection system.
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IV IEST RESULTS
The P| will provide a final report to ARC within 45 days ot the completion
of the test. In addition to a quantitative analysis ot the urine, an
examination of the urine samples for particulate matter and ejaculate is
very important.
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APPENDIX C
FEASIBILITY STUDY:
PRIMATE EXPERIMENT INTEGRATED TEST
73
TESTPLAN
PRIMATE XPERIMENTINTEGRATEDTEST
OCTOBER19 -29, 1984
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ARCSL-4 PRIMATE XPERIMENTINTEGRATEDHARDWARET STPLAN
1.0
2.0
BACKGROUND
A major milestone for SL-4 Moore-Ede/Fuller Squirrel MonkeyExperiment
hardware development will be an integrated test using fliqh-like
hardware and two monkeysubjects for the expected flight experiment
duration. The test will provide the first opportunity for the fliqht
crew to engage in training with flight equipment that interfaces with
the test subjects under simulated conditions. In order to successfully
conduct a test of this complexity, significant coordination must occur
amongthe participants. This plan is meant to provide a basis for that
coordination.
SCOPE
The two hardware test units will consist of SL-4 Primate Experiment
flight-like componentsexcept for the SIM RAHFand the Ground Support
Equipment. A woodenSIM RAHFwill simulate the actual flight RAHF
(none are available) and the Ground Support Equipment is expected to be
undergoing validation during this time period.
The procedures to be used for conducting the test will, in general,
follow those listed in the PDR and CDR for the experiments. The
preflight and postflight data collection periods will be shortened
however and the test will begin at L-2 days, include a 7-day flight
period and end at R+12 hours. This will require approximately 10
continuous days of operation for all equipment. Written procedures
should be followed during the test so that these can be evaluated as
well as the hardware. The major emphasis for the test is experiment
hardware verification. It is expected that deviations from the PDR/CDR
timelines will have to be made to focus on hardware evaluation, but any
procedures which can be readily evaluated should be performed whenever
possible. Post-test, deviations from the PDR/CDR timeline should be
noted and any possible hardware impact evaluated in anticipation of
conducting the upcoming Experiment Verification Test (EVT).
Both monkeys should be configured as as they will be for the flight
including ECG inplants, catheters, urine tubes and skin temperature
sensors. The monkeys will have been conditioned to at least lO-days of
restraint in the SL-4 cage including operation of the feeder and
waterer system. In order to maximize the possibility of successful
test completion, four monkeys should be surgically prepared and the
best two candidates chosen just prior to beginning the test.
Alldata should be recorded using the data acquisition schedule
#roposed for flight. Real-time test data will be recorded and will
include: ECG, venous pressure, heart rate, body temperature, five skin
temperatures and food consumption. The test will focus on hardware
performance and methodology, therefore a total data analysis will not
be attempted. The same rationale should apply to the biological
samples acquired during the test such as blood and urine. Validation
of hardware and procedures will be the main goals.
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3.0
3.1
3.2
All test-related animal activities will be conducted in a manner which
ensures that subjects will be maintained in a SPF (Specific Pathogen
Free) condition as specified in the LSFEP Animal Certification Plan.
Also, the recommendations of the Animal Verification Review panel will
be followed. These include following procedures such as maintaininq
controlled access to animal test areas and wearing of gowns and masks
by test personnel when in those areas.
PLAN/RESPONSIBILITES
Due to the unavailability of an actual flight RAHF, a wooden SIM RAHF
will be used to house both test subjects. The test will be conducted
within a controlled access trailer in the Animal Care Facility. The
trailer is partitioned in two to maintain SPF conditions in the actual
test area containing the animals.
Hardware Elements
SIM RAHF to contain:
Cage
Feeder system
Lixit waterer system (gravity bottle feed)
Restraint system
Urine collection system
Pressure measurement and blood sampling system
Signal conditioner package
Motor controller package
Power distribution box
Switch box
Data Select Panel to contain:
Launch/Re-entry recorder
400 Hz, 115V inverters
Carousel timer
Subject monitoring
LSLE, RAU buffering *
Data collection and display system
Centrifuge
Refrigerator/Freezer
The checkout of all test hardware elements will be accomplished by the
experiment team at ARC prior to the start of the test.
Animal Preparation and Care
Selection and Training Procedures
Responsibility of the ARC animal trainers with HMS and UCR
concurrence.
* Not in use during this test.
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4.0
5.0
Animal Preparation and Care Procedures
Catheter implantation - responsibility of HMS
ECG/DBT implantation responsibility of UCR with HMS concurrence
Temperature sensor attachment procedure - responsibility of UCR
Post-surgical animal care - ACF with HMS & UCR concurrence.
Catheter maintenance - ARC animal trainers with HMS concurrence.
All animal preparations, protocols and procedures will be subject to
review by the ARC Animal Care and Use Committee prior to the start of
the test.
TEST PREPARATION AND SCHEDULE
October 12 Prepare trailer, install SIM RAHF and check out lighting,
fans, etc.
October 13 Install 2 cages in SIM RAHF and check out cage subsystems
and data collection and display system.
October 18 Select 2 best test candidates. Both test candidates to be
shaved for skin sensor attachment and venous catheter lines
to be installed in both cages.
October 19 Begin 10-day test. Both test subjects to be fitted with
restraint jackets, skin sensors and urine tubes before
installation in cage and attachment to venous catheter line.
After cages are installed in SIM RAHF, data system is to be
checked out and light/dark cycle begun in trailer.
Begin flight procedures.
October 22 Crew arrives for training on flight procedures.
October 26 Crew departs after participating in debriefing with
experiment team and training personnel.
October 29 Remove test subjects, conduct clinical exam and return
animals to vivarium cages.
Conduct a post-test review with PIs and experiment team.
TEST PERSONNEL REQUIREMENTS
Due to the extensive coordination of hardware, animal subjects and test
personnel required to prepare for and conduct this test, it will be
mandatory that a test coordinator be assigned. The test coordinator
will have the responsibility for: (1) ensuring that this plan is
followed as closely as possible, (2) that appropriate notes are kept
throughout on both science and hardware concerns, (3) that Quality data
collection is maximized, (4) that the animal subject's well-beinq is
monitored appropriately by Bionetics animal health technicians and
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6.0
6.1
6.4
6.5
6.6
veternarians and (5) that access to the test area is controlled.
Since this test will be the first hands-on exposure of the crew to the
equipment, it is likely that some trouble-shooting and problem solving
will be required. The test conductor must act to ensure that the
appropriate personnel are available when needed and that the presence
of other personnel is minimized.
The key test support personnel are:
Test Coordinator
Primary Investigators
Project Directors
Experiment Manger
Engineering Manager
Experiment Design Engineer
Veterinarians
Animal Care/Support
Training Coordinator
N. Donnelly
C. Fuller (UCR); M. Moore-Ede & S.
Churchill (HMS)
J. Miller (UCR); S. Churchill (HMS)
H. Leon (ARC)
J. Connolly (ARC)
P. Fusco (ARC)
J. Goldsboro (ARC); D. Moore (Bionetics)
L. Mullin, M. Williams (Bionetics)
A. LaBoy (ARC)
TEST CONDUCT GUIDELINES
In order to maintain SPF conditions as closely as possible and to
ensure compliance with the ACF policy, the following guidelines are to
be observed.
Gowns and masks are to be worn when in the presence of a test subject.
In addition, gloves are to be worn when in contact with a test subject.
The ACF veterinarian has the final word on an animal's health status.
There will be no admittance to the test room without L. Mullin, M.
Williams or the ACF veterinarian present.
Contingency actions (other than animal health) will be decided by H.
Leon, J. Connolly and N. Donnelly.
Trailer keys will be maintained by H. Leon, J. Connolly, N. Donnelly,
L. Mullin and M. Williams.
Attendance in the animal prep room is to be restricted to active
participants, Pl's and staff and observers approved by the Test
Coordinator.
?9
APPENDIXA
DAILYACTIVITYSCHEDULES
8O
THRUSDAY10/18/84
1315 Select two test candidates
1330 Removeeach SMfrom vivarium cage and weigh.
1340 Share upper arms, upper thighs, and base of ta_l to prepare sites for
skin sensor placement.
1400 Return both SMto vivarium cages.
1415 Begin assembly and integration of venous catheter lines, transducers
and stopcocks into both cages.
1600 Complete integration/assembly.
Drape both cages with sterile cloth and leave in preparation room.
8!
ACTIVITYSCHEDULETESTDAYI
FRIDAY10/19/84
FIRST SM
0800
Room C8
0930
1. Take 1SM from vivarium cage and remove jacket.
2. Attach temperature sensors to animal's arms.
3. Place restraint jacket on SM and zip top half.
4. Place SM on table and attach 2 leg and tail temperature sensors.
5. Anchor strain relief tape.
6. Guide catheter lines, ECG/DBT probe and thermistor leads throuqh
jacket opening and zip lower jacket.
7. Place SM on table and attach urine collection system.
8. Install SM in restraint system.
9. Attach urine collection tube to urine valve.
I0. Connect Skin sensor leads to plug.
0945
1000
Remove SM/cage to trailer test site.
Connect catheter lines to pressure measurement and blood sampling
system.
1030 Checkout data displays for temperature, pressure and heart rate
readouts.
II00 I. Install cage in SIM RAHF.
2. Connect waterer tube to cage.
SECOND SM
0945 Repeat I - 10 above.
Room C8
1115
1130 Remove SM/cage to trailer test site.
. 1145 Connect catheter lines to pressure measuremment and blood sampling
system.
1200 Checkout data displays for temperature, pressure and heart rate
readouts.
1230 1..Install cage in SIM RAHF.
2. Connect waterer tube to cage.
1300 Begin test.
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ACTIVITY SCHEDULE - TEST DAYS 2, 3
SATURDAY 10/20/84 - SUNDAY 10/20/84
0930 1. Health check (ACF Vet)
2. Carousel changeout (L. Mullin/M. Williams)
3. Waste tray changeout (Day 3 only) (L. Mullin/M. Williams)
4. Feeder checkout (day 3 only)(L. Mullin/M. Williams)
5. Pressure transducer zeroing and measurement (J. Connolly)
6. Water replenishment (L. Mullin/M. Williams)
1000 Blood draw/re-infusion (S. Churchill)
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ACTIVITYSCHEDULE- TESTDAYS4, 5, 6, 7, 8
MONDAY I0/20/84 - FRIDAY 10/26/84
0930 1. Health check (ACF Vet) (Crew)
2. Carousel changeout (Crew)
3. Waste tray changeout (Crew)
4. Feeder checkout (Crew)
5. Pressure transducer zeroing and measurement (Crew)
6. Water replenishment (L. Mullin/M. Williams)
1000 Blood draw/re-infusion (Crew)
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ACTIVITYSCHEDULE- TESTDAYS9, 10
SATURDAY10/27/84 - SUNDAY10/28/84
0930 1. Health check (ACFVet)
2. Carousel changeout (L. Mullin/M. Williams)
3. Feeder checkout (Day 9) (L. Mullin/M. Williams)
4. Pressure transducer zeroing and measurement(J. Connolly)
5. Water replenishment (L. Mullin/M. Williams)
1000 Blood draw/re-infusion (S. Churchill)
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ACTIVITYSCHEDULE- TESTDAY11
MONDAY10/29/84
0930 1. Health check (ACFVet)
2. Carousel changeout (L. Mullin/M. Williams)
3. Waste tray changeout (L. Mullin/M. Williams)
4. Pressure transducer zeroing and measurment(J. Connolly)
1000 Blood draw/re-infusion (S. Churchill)
1045 1. Disconnect water lines, data cables and removecages from SIM RAHF
and place in C8.
Removeanimals from cages, conduct health inspection and weigh.
1115
1330
.
Return animals to vivarium cages.
Post-Test review.
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HARVARD MEDICAL SCHOOL
DEPARTMENT OF pHYSIOLOGY AND BIOPHYSICS
MEMORANDUM 21 November 1984
To"
Re:
From:
A11 Concerned
Integrated Hardware Test/Crew Training
October 19 - 29, 1984
Susanne E. Churchill, Ph.D.
Co-lnvestigator, Primate Experiment
During the hardware integration test and crew training of this past October
19th - 29th, a number of issues came up which I would like to bring to your
attention. While I realize this is yet another list documenting concerns, I
am doing this for the purposes of my own organization. Should there be any unique
items here, so much the better. As you will notice, most of these items pertain
to crew training issues.
Item 1 - Urine Collection System
a) Length of the urine tube should be standardized and should be of sufficient
length to provide some slack. The tube on one monkey appeared to be
stretched a bit too tightly around the restraint pole and may have
contributed/caused the penile "sore" observed during take down.
b) It was confirmed by the Specialists and the P.I. that the tubes should be
numbered consecutively from 1 to Ixx. At each change-out, only those
tubes which have cycled over the needle valve will be removed to stowage.
Consequently, it is imperative that the Specialist note what this tube was
prior to removing the carousel from the cradle. The first'tube in the
sequence which has not been punctured will then be moved up to slot no. I.
The remaining empty tubes in the carousel will also be moved forward and
the remaining slots filled by fresh tubes from stowage.
c) The Specialists requested that slot no. 1 be clearly marked as with a piece of
tape, since this will always note the reinstallation position.
d) It will be important that numbers denoting the position 180 degrees from the
forward-facing tube be very clear in order to ensure that all used tubes,
whether they contain urine or not, are removed.
e) All urine tubes will be labeled a second time with a Sharpie marker. This
will be especially important in the event of an out-of-sequence manoeuvre
or an error in the installation.
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From: SusanneE. Churchill, Ph.D.
f) A request was made by the Specialists to mark the tight screw-slot position
for each slot on all carousels.
g) It is imperative that we resolve the issue of timing of the urine carousel
change. This should occur as nearly as possible in increments of L + 4,
in order to capture that all-important first sample. In addition, the
Specialist must be aware of whatever this time will be in order not to change
out the carousel during a normal change cycle. As the cage door must be
closed following removal of the carousel, it is possible that a change command
could enter in the absence of a carousel with the result being that 8 hours
of urine would collect in the urine tube, posing a serious threat to the
competency of the system.
h) The Specialists determined that during carousel change out, the pit pin could
most easily be stored in its true slot unless this would be needed to secure
the carousel at the GPWS holder.
i) The issue still must be resolved of what to do in the event of a failure of
the urine valve. If this occurs, it will most likely be due to either a bent
needle or a clogged valve.
Item 2 - Blood Draw System
a) Velcro fastening systems will be needed on the RAHF outer door in two forms"
I. Opposing strips of velcro to serve as pockets, and
2. A one-sided velcro strip from which to hang the various blood draw
- packets. We will also need these for EVT.
b) The lO cc syringe should be graduated in tenths in order to ensure precise
delivery of the flush volume.
c) The plastic tips used for rinsing the stop cock should be replaced by stan-
dard luer hub adaptors, as it was difficult to install the plastic tips.
The pockets in each pack which are to be used for the restorage of sterile
items should be marked in large letters "STERILE" to avoid accidental
deposit of "trash" in these slots.
d) Problems with back-leak from the reactivials were serious enough to occasion
a re-work of this system. Ideally, whatever system is used would be as
small as possible, have a conical bottom to maximize plasma harvest, and
would, perhaps, carry a vacuum sufficient to automatically withdraw most,
but not all, of the expected plasma harvest. It is extremely important that
this vacuum not be excessive as red blood cells must not be delivered into
the storage vial, as would invariably occur with a stronger vacuum.
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e)
f)
The requirement for a larger air bleed syringe is emphasized again in
order to minimize the number of times that this is backfilled from the VSP
which tends to introduce red b_ood cells into this relatively static volume.
Although the air bleed syringe was not designed for this purpose, it
turns out to be the perfect system for flushing the catheter tip whenever
the Specialist has a few extra moments and would like to generate an
additional central venous pressure value for our experiment. Unfortunately,
while this method worked well on several occasions, it did not always seem
to free the catheter tip. There was a question from me that perhaps a
stopcock inserted in lieu of the T in the air bleed syringe-transducer-
VSP system might cure this problem. This issue may be resolved following
EVT when a flight-like cage is available to our laboratory. If this
procedure could be made to work reliably, it would result in an enormous
data gain for our experiment as the procedure is enormously simplified; in
the absence of such a straightforward procedure, it is unlikely that
Specialists will take the time and effort required.
g) Centrifuge
I. The absence of a break poses a serious problem to the time-lining of
- this experiment, as well as serving to greatly increase the time before
the sample is cooled.
2. The current red blood cell pack is not optimal. If possible, a spin
- at higher RPMs is desirable in order to increase the plasma harvest.
h) In order to facilitate hematocrit reading, a hematocrit reading device and
a recording log should be provided at some easily accessible location,
convenient to the Specialist.
Item 3 - Vascular Transducers
a) The Specialists have requested that the set screw be chanqed to a knob in order
to facilitate zeroing of the transducer. There is no need to bring this
knob forward in the cage.
b) There was general concern expressed regarding the zero stability of the
transducer as drifts in this would severely limit the collection of accurate
CVP data.
c) The positioning of the transducer within the cage must be standardized so
that a correction factor for zero offset can be determined and tested.
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Item 4 - Miscellaneous
a) Concern was expressed as to whether or not the stainless plenums covering
the feeder box and emergency water delivery hole would prevent a clear view
of the monkey.
b) The issue of what to do with garbage surfaced on several occasions. As
much of the refuse from the blood draw procedure should be considered a
biohazard, procedures must be developed to safely dispose of these materials.
c) The RAHF door when open must have a tethering system as the kits will be
hung on this door in a secure fashion.
d) The orientation of the Specialist doing the blood sampling has yet to be
determined, especially for the lower two cages. It is possible that special
restraint devices will be needed to provide comfortable access to the VSP.
e) A request was made by theSpecialists to fly an adequate supply of vacutainers
in the event that trouble-shooting of the urine system was required.
I would like to take this opportunity to thank all the individuals who worked so
hard to make this test and training session such a successful event. In particular,
we feel that the Engineering Staff has developed a series of unique and proficient
hardware items which will allow us to accomplish our proposed scientific goals
during the spaceflight. As before, the feedback from/and interaction with the
Payload and Mission Specialists has contributed significantly to the improvement
and streamlining of our experimental procedures.
Several of the above items are action items for this laboratory to resolve. We
look forward to expediting these issues as soon as a flight-like, fully equipped
cage can be made available to us. If the suggested target date of March I, 1985
can be met, we will make every effort to close out the remaining issues within a
6-month period so that the cage system can be returned to NASA ARC in preparation
for KSC ground support studies.
Thanks to all concerned.
With best wishes, Sincerely,
Susanne E. Churchill, Ph.D.
Co-lnvestigator and Project Director
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